This drug, Gefitinib, is used to treat a type of lung cancer (NSCLC) that has certain EGFR mutations, like exon 19 deletions or the L858R mutation. The key part of the drug blocks EGFR signaling, which is a thing that can make tumor cells grow. You get this in 250 mg tablet form.
Adults usually take one 250 mg tablet each day. You can take the tablets either with or without eating. Each bottle holds 30 of those 250 mg tablets.
